FilingSEC EDGAR8-K
Edesa Biotech Increases Executive Base Salaries
· SEC accepted
StageCompensation Adjustment
Filing content
Edesa Biotech approved increases to the annual base salaries of its CEO, President, and CFO, effective retroactively to July 1, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…